FDA | Institut Fraser

Who was Barbara Mitchell?

Janvier 13, 2024 3:30AM

FDA approval may spell trouble for Canadian patients

Steven Globerman

FDA approval may spell trouble for Canadian patients

In 2022, the United States accounted for 42.6 per cent of pharmaceutical sales worldwide compared to 2 per cent for Canada.

Étiquettes:

FDA, US FDA, canadian drug prices, american drug prices, drug shortage, drug supply

Janvier 4, 2017 12:00PM

Cures Act ensures U.S. will continue to outperform Canada in approving new medicines

The FDA is fundamentally reforming its drug approval process.

Étiquettes:

FDA, access to new drugs, new prescription drugs, access to health care, canadian drug approval

Avril 13, 2012 2:00AM

Easy access to new prescription drugs depends on where you live

Question: Should patients in Rome or Detroit have faster access to new prescription drugs than someone living in Victoria or Windsor? If your answer to that is no, then here is another query: Why do government agencies tasked to approve or deny new drugs in Europe and the United States (and which presumably have the same high standards as Canada) act quicker when compared to Health Canada?

Étiquettes:

prescription drugs, new medicine, new drugs, drug approval process, health canada, FDA, EMA, european medicine agency, american food and drug adminstration

Avril 4, 2012 2:00AM

Access Delayed, Access Denied: Waiting for New Medicines in Canada: 2012

Brett J. Skinner, Mark Rovere

Étiquettes:

new medicine, drug approval process, new drugs, access to new drugs, FDA, health canada, drug insurance, public drug insurance

Juin 29, 2011 2:00AM

Access Delayed, Access Denied: Waiting for New Medicines in Canada 2011

Mark Rovere, Brett J. Skinner

Étiquettes:

new medicine, drug approval process, new drugs, access to new drugs, FDA, health canada, drug insurance, public drug insurance

Mars 17, 2010 3:00AM

Access Delayed, Access Denied: Waiting for New Medicines in Canada 2010

Brett J. Skinner, Mark Rovere

Étiquettes:

new medicine, drug approval process, new drugs, access to new drugs, FDA, health canada, drug insurance, public drug insurance

Août 17, 2009 2:00AM

Access Delayed, Access Denied: Waiting for New Medicines in Canada 2009

Brett J. Skinner, Mark Rovere

Étiquettes:

new medicine, drug approval process, new drugs, access to new drugs, FDA, health canada, drug insurance, public drug insurance

Avril 2, 2008 2:00AM

Access Delayed, Access Denied: Waiting for New Medicines in Canada 2008

Brett J. Skinner, Mark Rovere

Étiquettes:

new medicine, drug approval process, new drugs, access to new drugs, FDA, health canada, drug insurance, public drug insurance

Mars 15, 2007 3:00AM

Access Delayed, Access Denied: Waiting for New Medicines in Canada 2007

Brett J. Skinner, Mark Rovere, Courtney Glen

Étiquettes:

new medicine, drug approval process, new drugs, access to new drugs, FDA, health canada, drug insurance, public drug insurance